owned
AKOUOS, INC.
owned
AKOUOS, INC.
Trademarks owned by 'AKOUOS, INC.'
Summary of page content
2021-01-08
US
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
genetic testing for medical purposes; genetic counseling; providing website featuring educational information regarding genetic testing and genetic counseling for individuals with a clinical diagnosis of auditory neuropathy; charitable services, namely, providing genetic testing and genetic counseling free of charge to individuals with a clinical diagnosis of auditory neuropathy
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-12
2021-04-09
nc capital management dispatch elixir hearing media networks consumers group
2021-01-08
US
The mark consists of the stylized word "resonate" in dark blue with a blue and teal wave going through the word, appearing above the smaller stylized words "BY AKOUOS" fading from blue with a blue and teal wave going through the words, all appearing to the right of a blue and teal sound wave design.
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
genetic testing for medical purposes; genetic counseling; providing website featuring educational information regarding genetic testing and genetic counseling for individuals with a clinical diagnosis of auditory neuropathy; charitable services, namely, providing genetic testing and genetic counseling free of charge to individuals with a clinical diagnosis of auditory neuropathy
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-04-08
2021-04-09
nc capital management dispatch elixir hearing media networks consumers group
2021-01-08
US
The mark consists of the stylized word "resonate" appearing above the stylized words "BY AKOUOS", all appearing to the right of a sound wave design.
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
genetic testing for medical purposes; genetic counseling; providing website featuring educational information regarding genetic testing and genetic counseling for individuals with a clinical diagnosis of auditory neuropathy; charitable services, namely, providing genetic testing and genetic counseling free of charge to individuals with a clinical diagnosis of auditory neuropathy
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-04-08
2021-04-09
nc capital management dispatch elixir hearing media networks consumers group
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
providing a website featuring education information regarding inner ear disorders and conditions, hearing loss and genetics
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-02-04
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-02-04
AKOUOS Akouos, Inc.
2020-11-20
US
-
5
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss; gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
5
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss; gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
10
Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
drug delivery systems; viral vector delivery platforms for gene therapy; medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
10
Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
drug delivery systems; viral vector delivery platforms for gene therapy; medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
providing a website featuring education information regarding inner ear disorders and conditions, hearing loss and genetics
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
5
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss; gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
5
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss; gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
10
Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
drug delivery systems; viral vector delivery platforms for gene therapy; medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
10
Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
drug delivery systems; viral vector delivery platforms for gene therapy; medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
providing a website featuring education information regarding inner ear disorders and conditions, hearing loss and genetics
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-01-29
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
providing a website featuring education information regarding inner ear disorders and conditions, hearing loss and genetics
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-02-04
AKOUOS Akouos, Inc.
2020-11-20
US
The mark consists of the word "AKOUOS" with segmented letters in a wave form.
-
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (aav) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
630
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
2021-01-26
2021-02-04
AKOUOS Akouos, Inc.
2016-11-14
US
-
5
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating of diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
-
10
Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
drug delivery systems; medical devices for use in treating of diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
606
ABANDONED - NO STATEMENT OF USE FILED
2020-12-28
2020-12-28
AKOUOS AKOUOS, INC.